Published December 21, 1999
| Version v1
Patent
Formulation for tin-117m/diethylenetriaminepentaacetic acids
Description
The invention provides improved formulations of 117mSn (Sn4+) DTPA which allow higher doses of 117mSn (Sn4+) to be administered than were previously possible. Methods for making pharmaceutical compositions comprising 117mSn (Sn4+) DTPA in which the amount of unchelated DTPA is minimized are disclosed along with methods of using the improved formulations, both for palliation of bone pain associated with cancer and for treatment of osseous tumors
Availability note (English)
Available from Patent and Trademark Office, Box 9, Washington, DC 20232 (US)Additional details
Publishing Information
- Imprint Pagination
- [10 p.]
- IPC:
- Int. Cl. A61K 51/00; A61M 36/14
- IPC
- Int. Cl. A61K 51/00; A61M 36/14
- Patent number
- US patent document 9-093,200
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 31024816
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE; S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Resource subtype / Literary indicator
- Non-conventional Literature
- Descriptors DEI
- CHEMICAL PREPARATION; NEOPLASMS; PAIN; RADIOPHARMACEUTICALS; RADIOTHERAPY; SKELETON; TIN 117
- Descriptors DEC
- BODY; DAYS LIVING RADIOISOTOPES; DISEASES; DRUGS; EVEN-ODD NUCLEI; INTERMEDIATE MASS NUCLEI; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; NUCLEI; ORGANS; RADIOACTIVE MATERIALS; RADIOISOTOPES; STABLE ISOTOPES; SYMPTOMS; SYNTHESIS; THERAPY; TIN ISOTOPES
Optional Information
- Notes
- AC02-98CH10886
- Secondary number(s)
- US patent application 9-093,200